On March 3, 2025, the FDA approved Celltrion’s denosumab biosimilars, STOBOCLO® (denosumab-bmwo; 60 mg/mL injection) and OSENVELT® (denosumab-bmwo; 70 mg/mL injection), referencing Amgen’s ...

It might become a family affair in East Lansing. On Thursday, On3 reported that four-star athlete Salesi Moa set an early official visit with Michigan State for the weekend of April 2. Moa's ...

In 1934, the NZ Herald reported on moa remains discovered in a swamp on a Canterbury farm. Photo / Mark Mitchell Kem Ormond takes a look at the world of farming back in the day. Moa were large ...

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

The biosimilar approval was based on a comprehensive clinical data package, which included a double-blind, randomized, active-controlled phase 3 trial (ClinicalTrials.gov Identifier: NCT04757376) that ...

His emergence could solidy the depth at linebacker gievn the departures of the Moa brothers. Like Ethan Thomason, Hunter Clegg just returned home from his mission in December. Clegg is one of the ...

Findings from a phase 3 trial showed denosumab-dssb had comparable efficacy, safety, immunogenicity, PK and PD to Prolia in patients with postmenopausal osteoporosis. Ospomyv is approved to treat ...

Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...

The approvals are based on a comprehensive clinical data package, which included a phase 1 trial (NCT04621318) comparing denosumab-dssb to the reference product (European Union sourced and United ...

The denosumab biosimilar market is poised for disruption with 3 FDA-approved biosimilars, at least 5 awaiting approval, and launches anticipated to start in May 2025, while ongoing patent litigation ...

In the MediPlus database, 43,486 patients had a diagnosis of type 2 diabetes. Of the 11,543 who had their first observed diagnosis between 2003 and 2005, 9,158 patients (54% male) met the ...

The results of this study suggest that the retrospective trajectories of BMIs in patients with newly-acquired diabetes are similar to those in healthy individuals. To the best of our knowledge ...